Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 4Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 4Adenomatous Polyposis Coli 4Colonic Neoplasms 3Rectal Neoplasms 1Precancerous Conditions 1Pancreatic Intraductal Neoplasms 1Colonic Polyps 1

Interventions

Biopsy 4Polymerase Chain Reaction 3Gene Expression Profiling 3Selenium 2Mass Spectrometry 2Light Coagulation 2Immunohistochemistry 2Endoscopy 2Endoscopic Mucosal Resection 2Aspirin 2alpha-Tocopherol 1Watchful Waiting 1Vitamin E 1Sulindac 1Rosuvastatin Calcium 1Papanicolaou Test 1Methylation 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1High-Throughput Screening Assays 1Genetic Linkage 1Gastroscopes 1Esomeprazole 1Erlotinib Hydrochloride 1Endoscopy, Digestive System 1DNA Methylation 1Counseling 1Comparative Genomic Hybridization 1Cidofovir 1Chromatography, Liquid 1Chromatography, Gas 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Sulindac × Gastrointestinal × Clear all
NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

National Cancer Institute (NCI)

Phase 2 Completed
85 enrolled 10 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡